Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,023,438 papers from all fields of science
Search
Sign In
Create Free Account
Folotyn
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
2 ML Pralatrexate 20 MG/ML Injection [Folotyn]
Broader (1)
Pralatrexate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Belinostat for Peripheral T-Cell Lymphoma
D. Radeski
,
A. Sawas
,
O. O’Connor
2014
Corpus ID: 68413899
the peripheral t-cell lymphomas (ptCLs) are a diverse group of mature t-cell neoplasms that typically display aggressive clinical…
Expand
Review
2012
Review
2012
Pralatrexate (Folotyn).
William Abramovits
,
Marcial Oquendo
,
Patricia Granowski
,
Aditya Gupta
,
Jennifer Cather
SKINmed Dermatology for the Clinician
2012
Corpus ID: 22907483
T-cell lymphoma accounts for 10% to 15% of all cases of non-Hodgkin lymphoma in the United States (approximately 5000 to 6000…
Expand
Review
2011
Review
2011
Efficacy of Short Oral Leucovorin Rescue (SOLR) In Managing Recurrent Pralatrexate (Folotyn) Induced Mucositis (RPIM) Despite Dose Reduction
P. Haddad
2011
Corpus ID: 78985420
Abstract 4745 Mucositis is a frequent complication experienced by patients receiving weekly Pralatrexate, an antifolate agent…
Expand
2010
2010
Pralatrexate injection (Folotyn): Folate analogue metabolic inhibitor approved for treatment of relapsed or refractory peripheral T-cell lymphoma
F. Staff
2010
Corpus ID: 71021263
New molecular entity: Pralatrexate injection (Folotyn) was approved on September 24, 2009, for the treatment of patients with…
Expand
2010
2010
Pralatrexate in patients with relapsed/refractory peripheral T-cell lymphoma (PTCL): Relationship between response and survival.
A. Shustov
,
B. Pro
,
+4 authors
O. O’Connor
2010
Corpus ID: 75444687
8054 Background: Pralatrexate (FOLOTYN) is a targeted antifolate designed for preferential uptake and accumulation in tumor cells…
Expand
2010
2010
Pralatrexate (Folotyn) for peripheral T-cell lymphoma.
The Medical letter on drugs and therapeutics
2010
Corpus ID: 9751903
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required